DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,088 filers reported holding DANAHER CORPORATION in Q2 2016. The put-call ratio across all filers is 0.21 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $20,083,000 | -16.3% | 234,808 | -23.9% | 0.60% | -20.0% |
| Q4 2016 | $24,003,000 | +5.1% | 308,367 | +5.8% | 0.75% | +6.3% |
| Q3 2016 | $22,838,000 | -19.8% | 291,337 | +3.3% | 0.71% | -26.0% |
| Q2 2016 | $28,489,000 | +9.7% | 282,067 | +3.0% | 0.96% | +11.4% |
| Q1 2016 | $25,978,000 | +24.1% | 273,852 | +21.5% | 0.86% | +19.1% |
| Q4 2015 | $20,928,000 | +427.6% | 225,324 | +384.0% | 0.72% | +468.5% |
| Q3 2015 | $3,967,000 | +6.0% | 46,554 | +6.5% | 0.13% | +8.5% |
| Q2 2015 | $3,743,000 | +62.2% | 43,731 | +60.9% | 0.12% | +62.5% |
| Q1 2015 | $2,307,000 | -0.9% | 27,175 | 0.0% | 0.07% | +4.3% |
| Q4 2014 | $2,329,000 | +12.8% | 27,175 | 0.0% | 0.07% | +263.2% |
| Q3 2014 | $2,065,000 | +6.3% | 27,175 | +10.2% | 0.02% | -68.9% |
| Q2 2014 | $1,942,000 | +18.3% | 24,665 | +12.7% | 0.06% | +8.9% |
| Q1 2014 | $1,641,000 | +6.8% | 21,883 | +9.9% | 0.06% | +3.7% |
| Q4 2013 | $1,537,000 | -82.7% | 19,915 | -84.5% | 0.05% | -84.2% |
| Q3 2013 | $8,908,000 | -9.6% | 128,506 | -17.5% | 0.34% | -9.8% |
| Q2 2013 | $9,857,000 | – | 155,711 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |